The Octane Medical Innovation Forum invites startups, investors, businesses, professionals, and visionaries in the Medtech, pharma, and healthcare sector, to attend the largest medical conference in Southern California on Entrepreneurial Intelligence. Attendees can participate in two days of robust networking with peers and senior-level professionals, connect with the dignitaries, and leverage the immense store of information available on the forum platform.
The Medical Innovation Forum is organized by Octane, a convening organization operating for the last 20 years in Southern California to connect companies with capital and resources. Octane hosts programs every year connecting entrepreneurs, global leaders, and investors.
The agenda of the medical forum is to discuss entrepreneurial intelligence and enable young companies to draw relevant strategies to get discovered by investors. Entrepreneurs can connect with influential strategic advisors who will provide tips and relevant plans of action to aid early-stage companies in achieving their business goals. They will discuss how AI can be incorporated into the organization to extract data and make plans.
Panel discussions include how the current macroeconomic recession has impacted investors and entrepreneurs. Further, budding companies will learn tips and tricks on how to successfully navigate their way through these hurdles. Other discussions will include the reasons behind medical innovation and how it has helped businesses expand. Experts will also offer insights on taking a meticulous course of action in future so that the company continues to evolve and does not become obsolete.
This event will be attended by a global faculty of eminent keynote speakers who will present their valuable opinions and discuss the changes needed in the medical industry for businesses to meet patient demands and evolve as per changing needs. They will also discuss funding capital issues and how businesses can position themselves for visibility from investors.
Medical experts will review the impact of diversity on ROI at different stages of business development. Agenda also includes discussing the importance of a diverse business team and diverse clinical trials to optimize products and sales in these fast-paced times. They will outline the key steps involved in successfully diversifying at the outset stages of business development to ensure optimal results.
The main focus of the event is to ensure medical innovation that paves way for the growth of professionals to meet patient demands, leading to company leadership and success.
To learn more, please visit https://ibn.fm/4D4pF.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.